Related Experiment Video

Updated: Jun 2, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K

Advances in Understanding How RhoB Regulates Akt Inhibition Efficacy in NSCLC

Nurullah Akgun1, Zekai Halici1, Elif Cadirci1

  • 1Department of Pharmacology, Faculty of Medicine, Ataturk University, 25240, Erzurum, Turkey.

Current Cancer Drug Targets
|January 17, 2025
PubMed
Abstract

Insights

RhoB negatively regulates the anti-tumor effects of Akt inhibition in non-small cell lung cancer (NSCLC). Silencing RhoB enhances the efficacy of Akt inhibitors, increasing apoptosis and reducing proliferation in NSCLC cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Akt inhibition is a promising strategy for lung cancer treatment.
  • Understanding regulatory mechanisms is crucial for enhancing Akt inhibitor effectiveness.

Purpose of the Study:

  • To investigate the role of RhoB in regulating Akt inhibition in non-small cell lung cancer (NSCLC).
  • To determine if RhoB modulates the anti-tumor activity of Akt inhibitors in NSCLC.

Main Methods:

  • Utilized the A549 NSCLC cell line.
  • Performed RhoB knockdown using small interfering RNA (siRNA).
  • Treated cells with perifosine (Akt inhibitor) and assessed proliferation, pAkt levels, and apoptosis.

Main Results:

  • RhoB upregulation reduced the antiproliferative activity of the Akt inhibitor.
  • RhoB silencing significantly lowered pAkt levels and increased apoptosis rates when combined with Akt inhibition.
  • RhoB acts as a negative regulator of Akt inhibitor efficacy in NSCLC cells.

Conclusions:

  • RhoB is identified as a negative regulator of anti-tumor activity in Akt-inhibited NSCLC.
  • RhoB expression levels may be a critical factor in predicting response to Akt inhibition therapy.
  • Targeting RhoB could offer novel therapeutic strategies for NSCLC treatment.
Keywords:
AktApoptosisBcl2l11ELISARhoBlung cancerxCELLigence

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.0K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.8K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K